[{"tweet_id":"1600109355235512321","screen_name":"FrenzyCapital","user_name":"Frenzy Cap","full_text":"Trending: Health Tech\n\n$BRTX 4.02 %\n$GOSS 0.11 %\n$SMMT 3.18 %\n$TLRY 0.43 %\n$ILMN 0.88 %\n$OTIC 6.11 %\n$CPHI -7.98 %\n$JAGX 3.36 %\n$RIGL -0.46 %\n$EDIT 9.36 %\n\nhttps://t.co/WV3qS0l6fi","sentiment":"neu","source":"<a href=\"http://www.jpfurtak.com:8080\" rel=\"nofollow\">trendingtickers2</a>","create_at":"Tue Dec 06 12:46:13 +0000 2022"},{"tweet_id":"1600109038821261312","screen_name":"BertrandBio","user_name":"Bertrand Delsuc","full_text":"Akeso #ASCO22 data for ivonescimab/AK112/SMT112 in NSCLC (PD-1 x VEGF bsAb) $SMMT  (BTD in China recently) https://t.co/M5JaRghTqo https://t.co/YKZijP6i26","sentiment":"neu","source":"<a href=\"https://mobile.twitter.com\" rel=\"nofollow\">Twitter Web App</a>","create_at":"Tue Dec 06 12:44:58 +0000 2022"}]
